Fanconi anaemia and leukaemia - Clinical and molecular aspects

British Journal of Haematology

Volumn 126, Issue 2, 2004, Pages 176-191

  Tischkowitz, Marc ^a   Dokal, Inderjeet ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Acute myeloid leukaemia; Bone marrow failure; Chromosome breakage; Deoxyribonucleic acid repair; Fanconi anaemia

Indexed keywords

ATM PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DNA; FLUDARABINE; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NIBRIN; OXYGEN; OXYMETHOLONE; PROTEIN; UNCLASSIFIED DRUG;

ACNE; APOPTOSIS; AUTOSOMAL RECESSIVE DISORDER; CANCER RISK; CHROMOSOME ABERRATION; CHROMOSOME DISORDER; CLINICAL FEATURE; CYTOGENETICS; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DNA DAMAGE; DNA REPAIR; FANCONI ANEMIA; GENE MUTATION; GENE THERAPY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HEMATOPOIESIS; HETEROZYGOTE; HIGH RISK POPULATION; HLA MATCHING; HUMAN; LEUKEMIA; LIVER CARCINOMA; MEDICAL ASSESSMENT; MOLECULAR BIOLOGY; MOLECULAR CLONING; MOLECULAR GENETICS; MOSAICISM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; SIDE EFFECT; SOLID TUMOR; STEM CELL TRANSPLANTATION; TELOMERE; TOXICITY;

ACUTE DISEASE; CHROMOSOME BREAKAGE; DNA REPAIR; FANCONI ANEMIA; GENE THERAPY; GENETIC COMPLEMENTATION TEST; HISTOCOMPATIBILITY TESTING; HUMANS; LEUKEMIA, MYELOID; STEM CELL TRANSPLANTATION;

EID: 3242658933     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05023.x     Document Type: Review

References (166)

1. Adachi, D., Oda, T., Yagasaki, H., Nakasato, K., Taniguchi, T., D'Andrea, A.D., Asano, S. & Yamashita, T. (2002) Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants. Human Molecular Genetics, 11, 3125-3134.
2. Agoulnik, A.I., Lu, B., Zhu, Q., Truong, C., Ty, M.T., Arango, N., Chada, K.K. & Bishop, C.E. (2002) A novel gene, Pog, is necessary for primordial germ cell proliferation in the mouse and underlies the germ cell deficient mutation, gcd. Human Molecular Genetics, 11, 3047-3053.
3. Aker, M., Varadi, G., Slavin, S. & Nagler, A. (1999) Fludarabine-based protocol for human umbilical cord blood transplantation in children with Fanconi anemia. Journal of Pediatric Hematology Oncology, 21, 237-239.
4. Alter, B.P. (1994) Clinical features of Fanconi anaemia. In: Aplastic Anaemia: Acquired and Inherited (ed. by N.S. Young & B.P. Alter), pp. 275-308. W.B. Saunders, Philadelphia.
5. Alter, B.P. (1996) Fanconi anemia and malignancies. American Journal of Hematology, 53, 99-110.
6. Alter, B.P. (2002) Radiosensitivity in Fanconi anemia patients. Radiotherapy and Oncology, 62, 345-347.
7. Alter, B.P. (2003) Cancer in Fanconi anemia, 1927-2001. Cancer, 97, 425-440.
8. Alter, B.P., Frissora, C.L., Halperin, D.S., Freedman, M.H., Chitkara, U., Alvarez, E., Lynch, L., Adler-Brecher, B. & Auerbach, A.D. (1991) Fanconi's anaemia and pregnancy. British Journal of Haematology, 77, 410-418.
9. Alter, B.P., Caruso, J.P., Drachtman, R.A., Uchida, T., Velagaleti, G.V. & Elghetany, M.T. (2000) Fanconi anemia. Myelodysplasia as a predictor of outcome. Cancer Genetics and Cytogenetics, 117, 125-131.
10. Alter, B.P., Greene, M.H., Velazquez, I. & Rosenberg, P.S. (2003) Cancer in Fanconi anemia. Blood, 101, 2072.
11. Auerbach, A.D. (1988) A test for Fanconi's anemia. Blood, 72, 366-367.
12. Auerbach, A.D. (1993) Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Experimental Hematology, 21, 731-733.
13. Auerbach, A.D. & Allen, R.G. (1991) Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry. Cancer Genetics and Cytogenetics, 51, 1-12.
14. Auerbach, A.D. & Wolman, S.R. (1976) Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens. Nature, 261, 494-496.
15. Auerbach, A.D., Sagi, M. & Adler, B. (1985) Fanconi anemia: prenatal diagnosis in 30 fetuses at risk. Pediatrics, 76, 794-800.
16. Auerbach, A., Buchwald, M. & Joenje, H. (1999) Fanconi anaemia. In: The Genetic Basis of Human Cancer (ed. by B. Vogelstein & K.W. Kinzler), pp. 317-332. McGraw Hill Inc., New York.
17. Awan, A., Malcolm Taylor, G., Gokhale, D.A., Dearden, S.P., Will, A., Stevens, R.F., Birch, J.M. & Eden, T. (1998) Increased frequency of Fanconi anemia group C genetic variants in children with sporadic acute myeloid leukemia. Blood, 91, 4813-4814.
18. Ball, S.E., Gibson, F.M., Rizzo, S., Tooze, J.A., Marsh, J.C. & Gordon-Smith, E.C. (1998) Progressive telomere shortening in aplastic anemia. Blood, 91, 3582-3592.
19. Barber, L.M., McGrath, H.E., Meyer, S., Will, A.M., Birch, J.M., Eden, O.B. & Taylor, G.M. (2003) Constitutional sequence variation in the Fanconi anaemia group C (FANCC) gene in childhood acute myeloid leukaemia. British Journal of Haematology, 121, 57-62.
20. Berger, R., Bernheim, A., Gluckman, E. & Gisselbrecht, C. (1980) In vitro effect of cyclophosphamide metabolites on chromosomes of Fanconi anaemia patients. British Journal of Haematology, 45, 565-568.
21. Berger, R., Le Coniat, M. & Gendron, M.C. (1993) Fanconi anemia. Chromosome breakage and cell cycle studies. Cancer Genetics and Cytogenetics, 69, 13-16.
22. Boulad, F., Gillio, A., Small, T.N., George, D., Prasad, V., Torok-Castanza, J., Regan, A.D., Collins, N., Auerbach, A.D., Kernan, N.A. & O'Reilly, R.J. (2000) Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts. British Journal of Haematology, 111, 1153-1157.
23. Boultwood, J., Fidler, C., Kusec, R., Rack, K., Elliott, P.J., Atoyebi, O., Chapman, R., Oscier, D.G. & Wainscoat, J.S. (1997) Telomere length in myelodysplastic syndromes. American Journal of Hematology, 56, 266-271.
24. Boyer, M.W., Gross, T.G., Loechelt, B., Leemhuis, T., Filipovich, A. & Harris, R.E. (2003) Low risk of graft-versus-host disease with transplantation of CD34 selected peripheral blood progenitor cells from alternative donors for Fanconi anemia. Journal of Pediatric Hematology/Oncology, 25, 890-895.
25. Burgio, G.R., Gluckman, E. & Locatelli, F. (2003) Ethical reappraisal of 15 years of cord-blood transplantation. Lancet, 361, 250-252.
26. Butturini, A., Gale, R.P., Verlander, P.C., Adler-Brecher, B., Gillio, A.P. & Auerbach, A.D. (1994) Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry Study. Blood, 84, 1650-1655.
27. Callen, E., Samper, E., Ramirez, M.J., Creus, A., Marcos, R., Ortega, J.J., Olive, T., Badell, I., Blasco, M.A. & Surralles, J. (2002) Breaks at telomeres and TRF2-independent end fusions in Fanconi anemia. Human Molecular Genetics, 11, 439-444.
28. Cassinat, B., Guardiola, P., Chevret, S., Schlageter, M.-H., Toubert, M-E., Rain, J.-D. & Gluckman, E. (2000) Constitutive elevation of serum alpha-fetoprotein in Fanconi anemia. Blood, 96, 859-863.
29. Cassinat, B., Darsin, D., Guardiola, P., Toubert, M.-E., Rain, J.-D., Gluckman, E. & Schlageter, M.-H. (2001) Intermethod Discordance for α-fetoprotein measurements in Fanconi anemia. Clinical Chemistry, 47, 1405-1409.
30. Cavenagh, J.D., Richardson, D.S., Gibson, R.A., Mathew, C.G. & Newland, A.C. (1996) Fanconi's anaemia presenting as acute myeloid leukaemia in adulthood. British Journal of Haematology, 94, 126-128.
31. Centurion, S.A., Kuo, H.R. & Lambert, W.C. (2000) Damage-resistant DNA synthesis in Fanconi anemia cells treated with a DNA cross-linking agent. Experimental Cell Research, 260, 216-221.
32. Chen, M., Tomkins, D.J., Auerbach, W., McKerlie, C., Youssoufian, H., Liu, L., Gan, O., Carreau, M., Auerbach, A., Groves, T., Guidos, C.J., Freedman, M.H., Cross, J., Percy, D.H., Dick, J.E., Joyner, A.L. & Buchwald, M. (1996) Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nature Genetics, 12, 448-451.
33. Cheng, N.C., van De Vrugt, H.J., van Der Valk, M.A., Oostra, A.B., Krimpenfort, P., de Vries, Y., Joenje, H., Berns, A. & Arwert, F. (2000) Mice with a targeted disruption of the Fanconi anemia homolog FANCA. Human Molecular Genetics, 9, 1805-1811.
34. Clarke, A.A., Philpott, N.J., Gordon-Smith, E.C. & Rutherford, T.R. (1997) The sensitivity of Fanconi anaemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA crosslinking. British Journal of Haematology, 96, 240-247.
35. Condie, A., Powles, R.L., Hudson, C.D., Sheperd, V., Bevan, S., Yuille, M.R. & Houlston, R.S. (2002) Analysis of the Fanconi anaemia complementation group A gene in acute myeloid leukaemia. Leukemia Lymphoma, 43, 1849-1853.
36. de Cremoux, P., Gluckman, E., Podgorniak, M.P., Menier, C., Thierry, D., Calvo, F. & Socie, G. (1996) Decreased IL-1 beta and TNF alpha secretion in long-term bone marrow culture supernatant from Fanconi's anaemia patients. European Journal of Haematology, 57, 202-207.
37. Cumming, R.C., Lightfoot, J., Beard, K., Youssoufian, H., O'Brien, P.J. & Buchwald, M. (2001) Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nature Medicine, 7, 814-820.
38. D'Andrea, A.D. & Grompe, M. (2003) The Fanconi anaemia/BRCA pathway. Nature Reviews Cancer, 3, 23-34.
39. Damewood, M.D. (2001) Ethical implications of a new application of preimplantation diagnosis. Journal of the American Medical Association, 285, 3143-3144.
40. De Kerviler, E., Guermazi, A., Zagdanski, A.M., Gluckman, E. & Frija, J. (2000) The clinical and radiological features of Fanconi's anaemia. Clinical Radiology, 55, 340-345.
41. Deeg, H.J., Socie, G., Schoch, G., Henry-Amar, M., Witherspoon, R.P., Devergie, A., Sullivan, K.M., Gluckman, E. & Storb, R. (1996) Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood, 87, 386-392.
42. Djuzenova, C.S., Rothfuss, A., Oppitz, U., Speit, G., Schindler, D., Hoehn, H. & Flentje, M. (2001) Response to X-irradiation of Fanconi anemia homozygous and heterozygous cells assessed by the single-cell gel electrophoresis (comet) assay. Laboratory Investigation, 81, 185-192.
43. Dokal, I., Chase, A., Morgan, N.V., Coulthard, S., Hall, G., Mathew, C.G. & Roberts, I. (1996) Positive diepoxybutane test in only one of two brothers found to be compound heterozygotes for Fanconi's anaemia complementation group C mutations. British Journal of Haematology, 93, 813-818.
44. Donahue, S.L. & Campbell, C. (2002) A DNA double-strand break repair defect in Fanconi anemia fibroblasts. Journal of Biological Chemistry, 277, 46243-46247.
45. Dutrillaux, B., Aurias, A., Dutrillaux, A.M., Buriot, D. & Prieur, M. (1982) The cell cycle of lymphocytes in Fanconi anemia. Human Genetics, 62, 327-332.
46. Escarceller, M., Rousset, S., Moustacchi, E. & Papadopoulo, D. (1997) The fidelity of double strand breaks processing is impaired in complementation groups B and D of Fanconi anemia, a genetic instability syndrome. Somatic Cell and Molecular Genetics, 23, 401-411.
47. Escarceller, M., Buchwald, M., Singleton, B.K., Jeggo, P.A., Jackson, S.P., Moustacchi, E. & Papadopoulo, D. (1998) Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining. Journal of Molecular Biology, 279, 375-385.
48. Faivre, L., Guardiola, P., Lewis, C., Dokal, I., Ebell, W., Zatterale, A., Altay, C., Poole, J., Stones, D., Kwee, M.L., van Weel-Sipman, M., Havenga, C., Morgan, N., de Winter, J., Digweed, M., Savoia, A., Pronk, J., de Ravel, T., Jansen, S., Joenje, H., Gluckman, E. & Mathew, C.G. (2000) Association of complementation group and mutation type with clinical outcome in Fanconi anemia. European Fanconi Anemia Research Group. Blood, 96, 4064-4070.
49. de la Fuente, J., Reiss, S., McCloy, M., Vulliamy, T., Roberts, I.A., Rahemtulla, A. & Dokal, I. (2003) Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors. Bone Marrow Transplantation, 32, 653-656.
50. Futaki, M., Igarashi, T., Watanabe, S., Kajigaya, S., Tatsuguchi, A., Wang, J. & Liu, J.M. (2002) The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage. Carcinogenesis, 23, 67-72.
51. Galimi, F., Noll, M., Kanazawa, Y., Lax, T., Chen, C., Grompe, M. & Verma, I.M. (2002) Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors. Blood, 100, 2732-2736.
52. Garcia-Higuera, I., Kuang, Y., Näf, D., Wasik, J. & D'Andrea, A.D. (1999) Fanconi anemia proteins FANCA, FANCC, and FANCG/ XRCC9 interact in a functional nuclear complex. Molecular and Cellular Biology, 19, 4866-4873.
53. Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M.S., Timmers, C., Hejna, J., Grompe, M. & D'Andrea, A.D. (2001) Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Molecules and Cells, 7, 249-262.
54. German, J., Schonberg, S., Caskie, S., Warburton, D., Falk, C. & Ray, J.H. (1987) A test for Fanconi's anemia. Blood, 69, 1637-1641.
55. Giampietro, P.F., Verlander, P.C., Davis, J.G. & Auerbach, A.D. (1997) Diagnosis of Fanconi anemia in patients without congenital malformations: an International Fanconi Anemia Registry Study. American Journal of Medical Genetics, 68, 58-61.
56. Gluckman, E. (1990) Radiosensitivity in Fanconi anemia: application to the conditioning for bone marrow transplantation. Radiotherapy and Oncology, 18(Suppl. 1), 88-93.
57. Gluckman, E., Devergie, A. & Dutreix, J. (1983) Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation. British Journal of Haematology, 54, 431-440.
58. Gluckman, E., Broxmeyer, H.A., Auerbach, A.D., Friedman, H.S., Douglas, G.W., Devergie, A., Esperou, H., Thierry, D., Socie, G., Lehn, P., Cooper, S., English, D., Kurtzberg, J., Bard, J. & Boyse, E.A. (1989) Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. New England Journal of Medicine, 321, 1174-1178.
59. Gregory, Jr, J.J., Wagner, J.E., Verlander, P.C., Levran, O., Batish, S.D., Eide, C.R., Steffenhagen, A., Hirsch, B. & Auerbach, A.D. (2001) Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 98, 2532-2537.
60. Grewal, S.S., Kahn, J.P., MacMillan, M.L., Ramsay, N.K. & Wagner, J.E. (2004) Successful hematopoietic stem cell transplantation for Fanconi anemia from an unaffected HLA genotypically identical sibling selected using preimplantation genetic diagnosis. Blood, 103, 1147-1151.
61. Grompe, M. (2003) FANCL, as in ligase. Nature Genetics, 35, 113-114.
62. Guardiola, P., Socie, G., Pasquini, R., Dokal, I., Ortega, J.J., van Weel-Sipman, M., Marsh, J., Locatelli, F., Souillet, G., Cahn, J.Y., Ljungman, P., Miniero, R., Shaw, J., Vermylen, C., Archimbaud, E., Bekassy, A.N., Krivan, G., Di Bartolomeo, P., Bacigalupo, A. & Gluckman, E. (1998) Allogeneic stem cell transplantation for Fanconi Anaemia. Severe Aplastic Anaemia Working Party of the EBMT and EUFAR. European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation, 21(Suppl. 2), S24-27.
63. Guardiola, P., Pasquini, R., Dokal, I., Ortega, J.J., van Weel-Sipman, M., Marsh, J.C., Ball, S.E., Locatelli, F., Vermylen, C., Skinner, R., Ljungman, P., Miniero, R., Shaw, P.J., Souillet, G., Michallet, M., Bekassy, A.N., Krivan, G., Di Bartolomeo, P., Heilmann, C., Zanesco, L., Cahn, J.Y., Arcese, W., Bacigalupo, A. & Gluckman, E. (2000) Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood, 95, 422-429.
64. Guardiola, P., Kurre, P., Vlad, A., Cayuela, J.M., Esperou, H., Devergie, A., Ribaud, P., Socie, G., Richard, P., Traineau, R., Storb, R. & Gluckman, E. (2003) Effective graft-versus-leukaemia effect after allogeneic stem cell transplantation using reduced-intensity preparative regimens in Fanconi anaemia patients with myelodysplastic syndrome or acute myeloid leukaemia. British Journal of Haematology, 122, 806-809.
65. Guardiola, P., Socie, G., Li, X., Ribaud, P., Devergie, A., Esperou, H., Richard, P., Traineau, R., Janin, A. & Gluckman, E. (2004) Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome. Blood, 103, 73-77.
66. Gush, K.A., Fu, K.L., Grompe, M. & Walsh, C.E. (2000) Phenotypic correction of Fanconi anemia group C knockout mice. Blood, 95, 700-704.
67. Hanenberg, H., Batish, S.D., Pollok, K.E., Vieten, L., Verlander, P.C., Leurs, C., Cooper, R.J., Gottsche, K., Haneline, L., Clapp, D.W., Lobitz, S., Williams, D.A. & Auerbach, A.D. (2002) Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool. Experimental Hematology, 30, 410-420.
68. Hanson, H., Mathew, C.G., Docherty, Z. & Mackie Ogilvie, C. (2001) Telomere shortening in Fanconi anaemia demonstrated by a direct FISH approach. Cytogenetics and Cell Genetics, 93, 203-206.
69. Hirsch, B., Shimamura, A., Moreau, L., Baldinger, S., Hag-Alshiekh, M., Bostrom, B., Sencer, S. & D'Andrea, A.D. (2004) Biallelic BRCA2/ FANCD1 mutations: association with spontaneous chromosomal instability and solid tumors of childhood. Blood, 103, 2554-2559.
70. Hoehn, H., Kubbies, M., Schindler, D., Poot, M. & Rabinovitch, P.S. (1989) BrdU-Hoechst flow cytometry links the cell kinetic defect of Fanconi anaemia to oxygen hypersensitivity. In: Fanconi Anaemia, Clinical, Cytogenetic and Experimental Aspects (ed. by T.M. Schroeder-Kurth, A.D. Auerbach & G. Obe), pp. 162-173. Springer-Verlag, Berlin.
71. Houghtaling, S., Timmers, C., Noll, M., Finegold, M.J., Jones, S.N., Meyn, M.S. & Grompe, M. (2003) Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes and Development, 17, 2021-2035.
72. Howlett, N.G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., De Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G., Ikeda, H., Fox, E.A. & D'Andrea, A.D. (2002) Biallelic inactivation of BRCA2 in Fanconi anemia. Science, 297, 606-609.
73. Hussain, S., Witt, E., Huber, P.A., Medhurst, A.L., Ashworth, A. & Mathew, C.G. (2003) Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1. Human Molecular Genetics, 12, 2503-2510.
74. Ikeda, H., Matsushita, M., Waisfisz, Q., Kinoshita, A., Oostra, A.B., Nieuwint, A.W., De Winter, J.P., Hoatlin, M.E., Kawai, Y., Sasaki, M.S., D'Andrea, A.D., Kawakami, Y. & Joenje, H. (2003) Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2. Cancer Research, 63, 2688-2694.
75. Joenje, H. & Arwert, F. (2001) Connecting Fanconi anemia to BRCA1. Nature Medicine, 7, 406-407.
76. Joenje, H. & Gille, J.J.P. (1989) Oxygen metabolism and chromosomal breakage in Fanconi anaemia. In: Fanconi Anaemia: Clinical, Cytogenetic and Experimental Aspects of Fanconi Anaemia (ed. by T.M. Schroeder-Kurth, G. Obe & A.D. Auerbach), pp. 174-182. Springer-Verlag, Berlin.
77. Joenje, H., Arwert, F., Eriksson, A.W., de Koning, H. & Oostra, A.B. (1981) Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia. Nature, 290, 142-143.
78. Joenje, H., Levitus, M., Waisfisz, Q., D'Andrea, A., Garcia-Higuera, I., Pearson, T., van Berkel, C.G., Rooimans, M.A., Morgan, N., Mathew, C.G. & Arwert, F. (2000) Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A. American Journal of Human Genetics, 67, 759-762.
79. Kapelushnik, J., Or, R., Slavin, S. & Nagler, A. (1997) A fludarabine-based protocol for bone marrow transplantation in Fanconi's anemia. Bone Marrow Transplantation, 20, 1109-1110.
80. Koc, A., Pronk, J.C., Alikasifoglu, M., Joenje, H. & Altay, C. (1999) Variable pathogenicity of exon 43del (FAA) in four Fanconi anaemia patients within a consanguineous family. British Journal of Haematology, 104, 127-130.
81. Koomen, M., Cheng, N.C., van De Vrugt, H.J., Godthelp, B.C., van Der Valk, M.A., Oostra, A.B., Zdzienicka, M.Z., Joenje, H. & Arwert, F. (2002) Reduced fertility and hypersensitivity to mitomycin C characterize Fancg/Xrcc9 null mice. Human Molecular Genetics, 11, 273-281.
82. Kruyt, F.A., Dijkmans, L.M., van, d.B.T.K. & Joenje, H. (1996) Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines. Blood, 87, 938-948.
83. Kruyt, F.A.B., Hoshino, T., Liu, J.M., Joseph, P., Jaiswal, A.K. & Youssoufian, H. (1998) Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase. Blood, 92, 3050-3056.
84. Kupfer, G.M., Näf, D., Suliman, A., Pulsipher, M. & D'Andrea, A.D. (1997) The Fanconi anaemia proteins, FAA and FAC interact to form a nuclear complex. Nature Genetics, 17, 487-490.
85. Kutler, D.I., Singh, B., Satagopan, J., Batish, S.D., Berwick, M., Giampietro, P.F., Hanenberg, H. & Auerbach, A.D. (2003a) A 20 year perspective of the International Fanconi Anemia Registry (IFAR). Blood, 101, 1249-1256.
86. Kutler, D.I., Auerbach, A.D., Satagopan, J., Giampietro, P.F., Batish, S.D., Huvos, A.G., Goberdhan, A., Shah, J.P. & Singh, B. (2003b) High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Archives of Otolaryngology - Head and Neck Surgery, 129, 106-112.
87. Kutler, D.I., Wreesmann, V.B., Goberdhan, A., Ben-Porat, L., Satagopan, J., Ngai, I., Huvos, A.G., Giampietro, P., Levran, O., Pujara, K., Diotti, R., Carlson, D., Huryn, L.A., Auerbach, A.D. & Singh, B. (2003c) Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. Journal of the National Cancer Institute, 95, 1718-1721.
88. Lensch, M.W., Rathbun, R.K., Olson, S.B., Jones, G.R. & Bagby, G.C. Jr (1999) Selective pressure as an essential force in molecular evolution of myeloid leukemic clones: a view from the window of Fanconi anemia. Leukemia, 13, 1784-1789.
89. Lensch, M.W., Tischkowitz, M., Christianson, T.A., Reifsteck, C.A., Speckhart, S.A., Jakobs, P.M., O'Dwyer, M.E., Olson, S.B., Le Beau, M.M., Hodgson, S.V., Mathew, C.G., Larson, R.A. & Bagby, G.C. Jr (2003) Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia. Blood, 102, 7-16.
90. Leteurtre, F., Li, X., Guardiola, P., Le Roux, G., Sergere, J.C., Richard, P., Carosella, E.D. & Gluckman, E. (1999) Accelerated telomere shortening and telomerase activation in Fanconi's anaemia. British Journal of Haematology, 105, 883-893.
91. Levitus, M., Rooimans, M.A., Steltenpool, J., Cool, N.F., Oostra, A.B., Mathew, C.G., Hoatlin, M.E., Waisfisz, Q., Arwert, F., De Winter, J.P. & Joenje, H. (2004) Heterogeneity in Fanconi anemia: evidence for two new genetic subtypes. Blood, 103, 2498-2503.
92. Li, X., Leteurtre, F., Rocha, V., Guardiola, P., Berger, R., Daniel, M.T., Noguera, M.H., Maarek, O., Roux, G.L., de la Salmoniere, P., Richard, P. & Gluckman, E. (2003) Abnormal telomere metabolism in Fanconi's anaemia correlates with genomic instability and the probability of developing severe aplastic anaemia. British Journal of Haematology, 120, 836-845.
93. Liu, J.M., Auerbach, A.D. & Young, N.S. (1991) Fanconi anemia presenting unexpectedly in an adult kindred with no dysmorphic features. American Journal of Medicine, 91, 555-557.
94. Liu, J.M., Kim, S., Read, E.J., Futaki, M., Dokal, I., Carter, C.S., Leitman, S.F., Pensiero, M., Young, N.S. & Walsh, C.E. (1999) Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC). Human Gene Therapy, 10, 2337-2346.
95. Lo Ten Foe, J.R., Rooimans, M.A., Bosnoyan-Collins, L., Alon, N., Wijker, M., Parker, L., Lightfoot, J., Carreau, M., Callen, D.F., Savoia, A., Cheng, N.C., van Berkel, C.G., Strunk, M.H., Gille, J.J., Pals, G., Kruyt, F.A., Pronk, J.C., Arwert, F., Buchwald, M. & Joenje, H. (1996) Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nature Genetics, 14, 320-323.
96. Lo Ten Foe, J.R., Kwee, M.L., Rooimans, M.A., Oostra, A.B., Veerman, A.J., van Weel, M., Pauli, R.M., Shahidi, N.T., Dokal, I., Roberts, I., Altay, C., Gluckman, E., Gibson, R.A., Mathew, C.G., Arwert, F. & Joenje, H. (1997) Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance. European Journal of Human Genetics, 5, 137-148.
97. Lowy, D.R. & Gillison, M.L. (2003) A new link between Fanconi anemia and human papillomavirus-associated malignancies. Journal of the National Cancer Institute, 95, 1648-1650.
98. MacMillan, M.L., Auerbach, A.D., Davies, S.M., Defor, T.E., Gillio, A., Giller, R., Harris, R., Cairo, M., Dusenbery, K., Hirsch, B., Ramsay, N.K., Weisdorf, D.J. & Wagner, J.E. (2000) Haematopoietic cell transplantation in patients with Fanconi anaemia using alternate donors: results of a total body irradiation dose escalation trial. British Journal of Haematology, 109, 121-129.
99. MacMillan, M.L., Auerbach, A.D., Champagne, M.A., DeFor, T.E., Dusenbery, K.E., Slungaard, A., Poh-Lin, T., Weisdorf, D.J. & Wagner, J.E. (2003) High probability of survival after related and alternate donor hematopoietic cell transplantation for Fanconi anemia using fludarabine-based preparative therapy. Blood, 102(Suppl.), 1695 (Abstract).
100. Marcou, Y., D'Andrea, A., Jeggo, P.A. & Plowman, P.N. (2001) Normal cellular radiosensitivity in an adult Fanconi anaemia patient with marked clinical radiosensitivity. Radiotherapy and Oncology, 60, 75-79.
101. McCloy, M., Almeida, A., Daly, P., Vulliamy, T., Roberts, I.A. & Dokal, I. (2001) Fludarabine-based stem cell transplantation protocol for Fanconi's anaemia in myelodysplastic transformation. British Journal of Haematology, 112, 427-429.
102. de Medeiros, C.R., Silva, L.M. & Pasquini, R. (2001) Unrelated cord blood transplantation in a Fanconi anemia patient using fludarabine-based conditioning. Bone Marrow Transplantation, 28, 110-112.
103. Medhurst, A.L., Huber, P.A., Waisfisz, Q., de Winter, J.P. & Mathew, C.G. (2001) Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway. Human Molecular Genetics, 10, 423-429.
104. Meetei, A.R., de Winter, J.P., Medhurst, A.L., Wallisch, M., Waisfisz, Q., van de Vrugt, H.J., Oostra, A.B., Yan, Z., Ling, C., Bishop, C.E., Hoatlin, M.E., Joenje, H. & Wang, W. (2003a) A novel ubiquitin ligase is deficient in Fanconi anemia. Nature Genetics, 35, 165-170.
105. Meetei, A.R., Sechi, S., Wallisch, M., Yang, D., Young, M.K., Joenje, H., Hoatlin, M.E. & Wang, W. (2003b) A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Molecular and Cellular Biology, 23, 3417-3426.
106. Nakanishi, K., Taniguchi, T., Ranganathan, V., New, H.V., Moreau, L.A., Stotsky, M., Mathew, C.G., Kastan, M.B., Weaver, D.T. & D'Andrea, A.D. (2002) Interaction of FANCD2 and NBS1 in the DNA damage response. Nature Cell Biology, 4, 913-920.
107. Offit, K., Levran, O., Mullaney, B., Mah, K., Nafa, K., Batish, S.D., Diotti, R., Schneider, H., Deffenbaugh, A., Scholl, T., Proud, V.K., Robson, M., Norton, L., Ellis, N., Hanenberg, H. & Auerbach, A.D. (2003) Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia. Journal of the National Cancer Institute, 95, 1548-1551.
108. Pace, P., Johnson, M., Tan, W.M., Mosedale, G., Sng, C., Hoatlin, M., de Winter, J., Joenje, H., Gergely, F. & Patel, K.J. (2002) FANCE: the link between Fanconi anaemia complex assembly and activity. EMBO Journal, 21, 3414-3423.
109. Pagano, G. & Youssoufian, H. (2003) Fanconi anaemia proteins: major roles in cell protection against oxidative damage. Bioessays, 25, 589-595.
110. Pang, Q., Fagerlie, S., Christianson, T.A., Keeble, W., Faulkner, G., Diaz, J., Rathbun, R.K. & Bagby, G.C. (2000) The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors. Molecular and Cellular Biology, 20, 4724-4735.
111. Pang, Q., Keeble, W., Christianson, T.A., Faulkner, G.R. & Bagby, G.C. (2001) FANCC interacts with Hsp70 to protect hematopoietic cells from IFN- gamma/TNF-alpha-mediated cytotoxicity. EMBO Journal, 20, 4478-4489.
112. Pang, Q., Christianson, T.A., Keeble, W., Koretsky, T. & Bagby, G.C. (2002) The anti-apoptotic function of Hsp70 in the interferon-inducible double-stranded RNA-dependent protein kinase-mediated death signaling pathway requires the Fanconi anemia protein, FANCC. Journal of Biological Chemistry, 277, 49638-49643.
113. Pearson, T., Jansen, S., Havenga, C., Stones, D.K. & Joubert, G. (2001) Fanconi anemia. A statistical evaluation of cytogenetic results obtained from South African families. Cancer Genetics and Cytogenetics, 126, 52-55.
114. Potter, N.U., Sarmousakis, C. & Li, F.P. (1983) Cancer in relatives of patients with aplastic anemia. Cancer Genetics and Cytogenetics, 9, 61-65.
115. Rackoff, W.D. (1999) Treatment of bone marrow failure. In: Fanconi Anamia Standards for Clinical Care (ed. by J. Owen), pp. 9-20. Fanconi Anemia Research Fund, Inc., 1902 Jefferson Street, Suite 2, Eugene, Oregon 97405.
116. Reuter, T.Y., Medhurst, A.L., Waisfisz, Q., Zhi, Y., Herterich, S., Hoehn, H., Gross, H.J., Joenje, H., Hoatlin, M.E., Mathew, C.G. & Huber, P.A. (2003) Yeast two-hybrid screens imply involvement of Fanconi anemia proteins in transcription regulation, cell signaling, oxidative metabolism, and cellular transport. Experimental Cell Research, 289, 211-221.
117. Rey, J.P., Scott, R. & Muller, H. (1994) Apoptosis is not involved in the hypersensitivity of Fanconi anemia cells to mitomycin C. Cancer Genetics and Cytogenetics, 75, 67-71.
118. Ridet, A., Guillouf, C., Duchaud, E., Cundari, E., Fiore, M., Moustacchi, E. & Rosselli, F. (1997) Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome. Cancer Research, 57, 1722-1730.
119. Rischewski, J.R., Clausen, H., Leber, V., Niemeyer, C., Ritter, J., Schindler, D. & Schneppenheim, R. (2000) A heterozygous frameshift mutation in the Fanconi anemia C gene in familial T-ALL and secondary malignancy. Klinische Padiatrie, 212, 174-176.
120. Rosenberg, P.S., Greene, M.H. & Alter, B.P. (2003) Cancer incidence in persons with Fanconi's anemia. Blood, 101, 822-825.
121. Rosenberg, P.S., Huang, Y. & Alter, B.P. (2004) Individualized risks of first adverse events in patients with Fanconi anemia. Blood, Pre-published online April 1, 2004.
122. Rosendorff, J., Bernstein, R., Macdougall, L. & Jenkins, T. (1987) Fanconi anemia: another disease of unusually high prevalence in the Afrikaans population of South Africa. American Journal of Medical Genetics, 27, 793-797.
123. Rosselli, F. (1998) Fanconi anaemia syndrome and apoptosis: state of the art. Apoptosis, 3, 229-236.
124. Rosselli, F., Sanceau, J., Wietzerbin, J. & Moustacchi, E. (1992) Abnormal lymphokine production - a novel feature of the genetic disease Fanconi anemia: I. Involvement of interleukin-6. Human Genetics, 89, 42-48.
125. Rosselli, F., Sanceau, J., Gluckman, E., Wietzerbin, J. & Moustacchi, E. (1994) Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia: II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha. Blood, 83, 1216-1225.
126. Rosselli, F., Ridet, A., Soussi, T., Duchaud, E., Alapetite, C. & Moustacchi, E. (1995) p53-dependent pathway of radio-induced apoptosis is altered in Fanconi anemia. Oncogene, 10, 9-17.
127. Runger, T.M., Sobotta, P., Dekant, B., Moller, K., Bauer, C. & Kraemer, K.H. (1993) In-vivo assessment of DNA ligation efficiency and fidelity in cells from patients with Fanconi's anemia and other cancer-prone hereditary disorders. Toxicology Letters, 67, 309-324.
128. Sala-Trepat, M., Rouillard, D., Escarceller, M., Laquerbe, A., Moustacchi, E. & Papadopoulo, D. (2000) Arrest of S-phase progression is impaired in Fanconi anemia cells. Experimental Cell Research, 260, 208-215.
129. Schindler, D., Kubbies, M., Hoehn, H., Schinzel, A. & Rabinovitch, P.S. (1985) Presymptomatic diagnosis of Fanconi's anaemia. Lancet, 1, 937.
130. Schroeder, T.M., Tilgen, D., Kruger, J. & Vogel, F. (1976) Formal genetics of Fanconi's anemia. Human Genetics, 32, 257-288.
131. Schultz, J.C. & Shahidi, N.T. (1993) Tumor necrosis factor-alpha overproduction in Fanconi's anemia. American Journal of Hematology, 42, 196-201.
132. Seyschab, H., Friedl, R., Sun, Y., Schindler, D., Hoehn, H., Hentze, S. & Schroeder-Kurth, T. (1995) Comparative evaluation of diepoxybutane sensitivity and cell cycle blockage in the diagnosis of Fanconi anemia. Blood, 85, 2233-2237.
133. Shimamura, A. & D'Andrea, A.D. (2003) Subtyping of Fanconi anemia patients: implications for clinical management. Blood, 102, 3459.
134. Shimamura, A., Montes De Oca, R., Svenson, J.L., Haining, N., Moreau, L.A., Nathan, D.G. & D'Andrea, A.D. (2002) A novel diagnostic screen for defects in the Fanconi anemia pathway. Blood, 100, 4649-4654.
135. Smith, J., Andrau, J.C., Kallenbach, S., Laquerbe, A., Doyen, N. & Papadopoulo, D. (1998) Abnormal rearrangements associated with V(D)J recombination in Fanconi anemia. Journal of Molecular Biology, 281, 815-825.
136. Socie, G., Devergie, A., Girinski, T., Piel, G., Ribaud, P., Esperou, H., Parquet, N., Maarek, O., Noguera, M.H., Richard, P., Brison, O. & Gluckman, E. (1998) Transplantation for Fanconi's anaemia: long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning. British Journal of Haematology, 103, 249-255.
137. Stark, R., Thierry, D., Richard, P. & Gluckman, E. (1993a) Long-term bone marrow culture in Fanconi's anaemia. British Journal of Haematology, 83, 554-559.
138. Stark, R., Andre, C., Thierry, D., Cherel, M., Galibert, F. & Gluckman, E. (1993b) The expression of cytokine and cytokine receptor genes in long-term bone marrow culture in congenital and acquired bone marrow hypoplasias. British Journal of Haematology, 83, 560.
139. Stevens, R.F. & Meyer, S. (2002) Fanconi and Glanzmann: the men and their works. British Journal of Haematology, 119, 901-904.
140. Strathdee, C.A., Duncan, A.M. & Buchwald, M. (1992) Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9. Nature Genetics, 1, 196-198.
141. Swift, M. (1971) Fanconi anaemia in the genetics of neoplasia. Nature, 230, 370-373.
142. Swift, M., Caldwell, R.J. & Chase, C. (1980) Reassessment of cancer predisposition of Fanconi anemia heterozygotes. Journal of the National Cancer Institute, 65, 863-867.
143. Taniguchi, T. & D'Andrea, A.D. (2002) The Fanconi anemia protein,
144. Taniguchi, T., Garcia-Higuera, I., Xu, B., Gregory, R.C., Kim, S.-T., Lane, W.S., Kastan, M.B. & D'Andrea, A.D. (2002) Convergence of the Fanconi anaemia and ataxia telangiectasia signaling pathways. Cell, 109, 459-472.
145. Taniguchi, T., Tischkowitz, M., Ameziane, N., Hodgson, S.V., Mathew, C.G., Joenje, H., Mok, S.C. & D'Andrea, A.D. (2003) Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nature Medicine, 9, 568-574.
146. The Fanconi Anaemia/Breast Cancer Consortium (1996) Positional cloning of the Fanconi anaemia group A gene. Nature Genetics, 14, 324-328.
147. Timmers, C., Taniguchi, T., Hejna, J., Reifsteck, C., Lucas, L., Bruun, D., Thayer, M., Cox, B., Olson, S., D'Andrea, A.D., Moses, R. & Grompe, M. (2001) Positional cloning of a novel Fanconi anemia gene, FANCD2. Molecular Cell, 7, 241-248.
148. Tischkowitz, M., Ameziane, N., Waisfisz, Q., De Winter, J.P., Harris, R., Taniguchi, T., D'Andrea, A., Hodgson, S.V., Mathew, C.G. & Joenje, H. (2003) Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia. British Journal of Haematology, 123, 469-471.
149. Tischkowitz, M.D., Morgan, N.V., Grimwade, D., Eddy, C., Ball, S., Vorechovsky, I., Langabeer, S., Stoger, R., Hodgson, S.V. & Mathew, C.G. (2004) Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia. Leukemia, 18, 420-425.
150. Tonnies, H., Huber, S., Kuhl, J.S., Gerlach, A., Ebell, W. & Neitzel, H. (2003) Clonal chromosomal aberrations in bone marrow cells of Fanconi anemia patients: gains of the chromosomal segment 3q26q29 as an adverse risk factor. Blood, 101, 3872-3874.
151. Toraldo, R., Canino, G., Tolone, C., D'Avanzo, M., Porfirio, B., Hoehn, H., Schroeder-Kurth, T. & Pistoia, V. (1998) Variable response to the diepoxybutane test in two dizygotic twins with Fanconi's anemia and flow cytometry for diagnosis confirmation. Pediatric Hematology and Oncology, 15, 45-54.
152. Vandenberg, C.J., Gergely, F., Ong, C.Y., Pace, P., Mallery, D.L., Hiom, K. & Patel, K.J. (2003) BRCA1-independent ubiquitination of FANCD2. Molecular Cell, 12, 247-254.
153. Venkitaraman, A.R. (2003) A growing network of cancer-susceptibility genes. New England Journal of Medicine, 348, 1917-1919.
154. Venkitaraman, A.R. (2004) Tracing the network connecting BRCA and Fanconi anaemia proteins. Nature Reviews Cancer, 4, 266-276.
155. Verlander, P.C., Kaporis, A., Liu, Q., Zhang, Q., Seligsohn, U. & Auerbach, A.D. (1995) Carrier frequency of the IVS4 + 4 A → T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population. Blood, 86, 4034-4038.
156. Verlinsky, Y., Rechitsky, S., Schoolcraft, W., Strom, C. & Kuliev, A. (2001) Preimplantation diagnosis for Fanconi anemia combined with HLA matching. Journal of the American Medical Association, 285, 3130-3133.
157. Wagner, J.E., Tolar, J., Levran, O., Scholl, T., Deffenbaugh, A., Satagopan, J., Ben-Porat, L., Mah, K., Batish, S.D., Kutler, D.I., MacMillan, M.L., Hanenberg, H. & Auerbach, A.D. (2004) Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia and Fanconi anemia. Blood, 103, 3226-3229.
158. Waisfisz, Q., Morgan, N.V., Savino, M., de Winter, J.P., van Berkel, C.G., Hoatlin, M.E., Ianzano, L., Gibson, R.A., Arwert, F., Savoia, A., Mathew, C.G., Pronk, J.C & Joenje, H. (1999) Spontaneous functional correction of homozygous Fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism. Nature Genetics, 22, 379-383.
159. Wajnrajch, M.P., Gertner, J.M., Huma, Z., Popovic, J., Lin, K., Verlander, P.C., Batish, S.D., Giampietro, P.F., Davis, J.G., New, M.I. & Auerbach, A.D. (2001) Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry. Pediatrics, 107, 744-754.
160. Whitney, M.A., Royle, G., Low, M.J., Kelly, M.A., Axthelm, M.K., Reifsteck, C., Olson, S., Braun, R.E., Heinrich, M.C., Rathbun, R.K., Bagby, G.C. & Grompe, M. (1996) Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene. Blood, 88, 49-58.
161. de Winter, J.P., Waisfisz, Q., Rooimans, M.A., Van Berkel, C.G.M., Bosnoyan-Collins, L., Alon, N., Carreau, M., Bender, O., Demuth, I., Schindler, D., Pronk, J.C., Arwert, F., Hoehn, H., Digweed, M., Buchwald, M. & Joenje, H. (1998) The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nature Genetics, 20, 281-283.
162. de Winter, J.P., van Der Weel, L., de Groot, J., Stone, S., Waisfisz, Q., Arwert, F., Scheper, R.J., Kruyt, F.A., Hoatlin, M.E. & Joenje, H. (2000a) The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Human Molecular Genetics, 9, 2665-2674.
163. de Winter, J.P., Leveille, F., van Berkel, C.G., Rooimans, M.A., van Der Weel, L., Steltenpool, J., Demuth, I., Morgan, N.V., Alon, N., Bosnoyan-Collins, L., Lightfoot, J., Leegwater, P.A., Waisfisz, Q., Komatsu, K., Arwert, F., Pronk, J.C., Mathew, C.G., Digweed, M., Buchwald, M. & Joenje, H. (2000b) Isolation of a cDNA representing the Fanconi anemia complementation group E gene. American Journal of Human Genetics, 67, 1306-1308.
164. de Winter, J.P., Rooimans, M.A., van Der Weel, L., van Berkel, C.G., Alon, N., Bosnoyan-Collins, L., de Groot, J., Zhi, Y., Waisfisz, Q., Pronk, J.C., Arwert, F., Mathew, C.G., Scheper, R.J., Hoatlin, M.E., Buchwald, M. & Joenje, H. (2000c) The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nature Genetics, 24, 15-16.
165. Witt, E. & Ashworth, A. (2002) D-Day for BRCA2. Science, 297, 534.
166. Xie, Y., de Winter, J.P., Waisfisz, Q., Nieuwint, A.W., Scheper, R.J., Arwert, F., Hoatlin, M.E., Ossenkoppele, G.J., Schuurhuis, G.J. & Joenje, H. (2000) Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells. British Journal of Haematology, 111, 1057-1064.